All In Biotech

Drug Trial Radar · NCT06792136

A Study of ONO-1110 in Patients With Major Depressive Disorder

A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 103 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

103

Actual

Start

Jan 16, 2025

Primary completion

Apr 9, 2026

Study completion Apr 9, 2026

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Jan 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Major Depressive Disorder

Conditions

  • Major Depressive Disorder (MDD

Interventions

  • ONO-1110Drug

    ONO-1110 tablets once a day

  • PlaceboDrug

    Placebo tablets once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in HAM-D17(Hamilton depression rating scale 17 items) total score from baseline to Week 8 of the treatment periodTime frame: Up to 16 weeks

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • AK Clinic

    Fukuoka, Japan

  • Hiro Mental Clinic

    Fukuoka, Japan

  • Hirota Clinic

    Fukuoka, Japan

  • Kokorono Clinic Hirao

    Fukuoka, Japan

  • Kokorono Clinic Iizuka

    Fukuoka, Japan

  • Kokura Mental Clinic

    Fukuoka, Japan

  • Mental Clinic Sakurazaka

    Fukuoka, Japan

  • Shinseikai Kaku Mental Clinic

    Fukuoka, Japan

  • Uematsu Mental Clinic

    Fukuoka, Japan

  • Ichikawa Clinic

    Gunma, Japan

  • Higashi-Sapporo Mental Clinic

    Hokkaido, Japan

  • Kawamura Mental Clinic

    Hokkaido, Japan

  • Minami1jo Mental Clinic

    Hokkaido, Japan

  • Sapporo Kobushi Clinic

    Hokkaido, Japan

  • Shimode Mental Clinic

    Hokkaido, Japan

  • Tatsuta Clinic

    Hyōgo, Japan

  • Kishiro Mental Clinic

    Kanagawa, Japan

  • Yutaka Clinic

    Kanagawa, Japan

  • Harai Clinic

    Tokyo, Japan

  • Iidabashi Mental Clinic

    Tokyo, Japan

  • Ikebukuro Olive Mental Clinic

    Tokyo, Japan

  • Kitaikebukuro Kokoro No Clinic

    Tokyo, Japan

  • Maynds Tower Mental Clinic

    Tokyo, Japan

  • Meguroeki Higashiguchi Mental Clinic

    Tokyo, Japan

  • Monzen-nakacho Mental Clinic

    Tokyo, Japan

  • Niseikai Murakami Iin

    Tokyo, Japan

  • Nishi-Shinjuku Concieria Clinic

    Tokyo, Japan

  • Sakurazaka Clinic SophyAnce

    Tokyo, Japan

  • Sangenjaya Nakamura Mental Clinic

    Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.